Delivery Order SPE2DR25D3303-SPE2DR26F65P4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,540.59 to AmerisourceBergen Drug Corp for the supply of Divalproex Sodium Extended-Release 500 mg tablets (500-count bottles). The award was made on January 13, 2026, with an ultimate completion date of January 14, 2026, and represents a firm fixed-price, non-set-aside contract. This delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- Amerisourcebergen Drug Corp will provide 500 tablets of Divalproex Sodium Extended Release 500 mg to the Defense Logistics Agency under this firm fixed price delivery order. With a potential value of $1,910.68, performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 2, 2023. No set-aside designation was applied. As a prime contractor supporting DLA Troop Support Medical facilities, Amerisourcebergen has extensive experience providing...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $89,920 firm fixed price delivery order by the Defense Logistics Agency to supply 100 tablets of the generic anti-seizure medication Divalproex Sodium ER 250mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 24, 2023. The delivery order was issued against the DLA's Prime Vendor program, a multiple award...
- The Defense Logistics Agency awarded a delivery order valued at $3,060.11 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp operates...
- The Defense Logistics Agency awarded a delivery order valued at $2,622.00 to AmerisourceBergen Drug Corp for Depakote ER 250 mg tablets (100 count) on November 3, 2025, with a completion date of November 4, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,506.66 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,138.74 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) on December 1, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by December 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $233,930 delivery order to Amerisourcebergen Drug Corporation for 500 mg tablets of divalproex sodium extended release. The order is for 100 count bottles of the medication under firm fixed price terms. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion scheduled for July 19, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency routinely issues such delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Depakote DR 250 mg tablets (100-count units) with a ceiling value of $1,078.01. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution...
- The Defense Logistics Agency awarded a delivery order valued at $9,442.36 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle Capsules (100-count) on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under the company's larger pharmaceutical supply vehicle...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F65P4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,540.59 to AmerSourceBergen Drug Corp for the supply of Divalproex Sodium Extended Release 500 mg tablets (500 count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company is a subsidiary of Cencora, Inc., which operates under the AmerSourceBergen brand name. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a single-award IDC valued at up to $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The contract serves multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, providing essential pharmaceutical support across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/13/26 |